| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; mouse; 1:5000; loading ...; fig 3
| Ward A, Jessop F, Faris R, Shoup D, Bosio C, Peterson K, et al. Lack of the immune adaptor molecule SARM1 accelerates disease in prion infected mice and is associated with increased mitochondrial respiration and decreased expression of NRF2. PLoS ONE. 2022;17:e0267720 pubmed publisher |
| Matamoros Angles A, Karadjuzovic E, Mohammadi B, Song F, Brenna S, Meister S, et al. Efficient enzyme-free isolation of brain-derived extracellular vesicles. J Extracell Vesicles. 2024;13:e70011 pubmed publisher |
| Fremuntova Z, Hanusova Z, Soukup J, Mosko T, Matej R, Holada K. Simple 3D spheroid cell culture model for studies of prion infection. Eur J Neurosci. 2024;60:4437-4452 pubmed publisher |
| Jones E, Hill E, Linehan J, Nazari T, Caulder A, Codner G, et al. Characterisation and prion transmission study in mice with genetic reduction of sporadic Creutzfeldt-Jakob disease risk gene Stx6. Neurobiol Dis. 2024;190:106363 pubmed publisher |
| Ribes J, Patel M, Halim H, Berretta A, Tooze S, Kl xf6 hn P. Prion protein conversion at two distinct cellular sites precedes fibrillisation. Nat Commun. 2023;14:8354 pubmed publisher |
| Kostelanska M, Holada K. Prion Strains Differ in Susceptibility to Photodynamic Oxidation. Molecules. 2022;27: pubmed publisher |
| Uchiyama K, Hara H, Chida J, Pasiana A, Imamura M, Mori T, et al. Ethanolamine Is a New Anti-Prion Compound. Int J Mol Sci. 2021;22: pubmed publisher |
| Bistaffa E, Marín Moreno A, Espinosa J, De Luca C, Cazzaniga F, Portaleone S, et al. PMCA-generated prions from the olfactory mucosa of patients with Fatal Familial Insomnia cause prion disease in mice. elife. 2021;10: pubmed publisher |
| Fremuntova Z, Mosko T, Soukup J, Kucerova J, Kostelanska M, Hanusova Z, et al. Changes in cellular prion protein expression, processing and localisation during differentiation of the neuronal cell line CAD 5. Biol Cell. 2020;112:1-21 pubmed publisher |
| Kostylev M, Tuttle M, Lee S, Klein L, Takahashi H, Cox T, et al. Liquid and Hydrogel Phases of PrPC Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-β Oligomers. Mol Cell. 2018;72:426-443.e12 pubmed publisher |
| Lee J, Kim M, Li L, Velumian A, Aui P, Fehlings M, et al. Nogo receptor 1 regulates Caspr distribution at axo-glial units in the central nervous system. Sci Rep. 2017;7:8958 pubmed publisher |
| Uchiyama K, Tomita M, Yano M, Chida J, Hara H, Das N, et al. Prions amplify through degradation of the VPS10P sorting receptor sortilin. PLoS Pathog. 2017;13:e1006470 pubmed publisher |
| Wu B, McDonald A, Markham K, Rich C, McHugh K, Tatzelt J, et al. The N-terminus of the prion protein is a toxic effector regulated by the C-terminus. elife. 2017;6: pubmed publisher |
| Marshall K, Hughson A, Vascellari S, Priola S, Sakudo A, Onodera T, et al. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection. J Virol. 2017;91: pubmed publisher |
| Morales R, Hu P, Duran Aniotz C, Moda F, Diaz Espinoza R, Chen B, et al. Strain-dependent profile of misfolded prion protein aggregates. Sci Rep. 2016;6:20526 pubmed publisher |
| Moda F, Le T, Aulić S, Bistaffa E, Campagnani I, Virgilio T, et al. Synthetic prions with novel strain-specified properties. PLoS Pathog. 2015;11:e1005354 pubmed publisher |
| Evangelisti E, Cecchi C, Cascella R, Sgromo C, Becatti M, Dobson C, et al. Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers. J Cell Sci. 2012;125:2416-27 pubmed publisher |
